A new discovery could change how type 1 diabetes is diagnosed and managed in individuals of African descent, researchers say.
Type 1 diabetes, where the insulin-producing beta cells in the pancreas stop working in childhood or young adulthood, has always been attributed to an autoimmune process in which the immune system produces so-called autoantibodies that mistakenly attack the pancreas.
